🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Johnson & Johnson beats on Q3 earnings, guides higher

Published 10/13/2015, 07:38 AM
© Reuters.  J&J beats on Q3 earnings, guides higher
JNJ
-
ESZ24
-
1YMZ24
-
NQZ24
-

Investing.com - Health care conglomerate Johnson & Johnson (N:JNJ) reported better-than-expected third quarter earnings and provided upbeat guidance for the year ahead, sending its shares higher in pre-market trade.

J&J said adjusted earnings per share came in at $1.49 in the quarter ended September 30, beating expectations for earnings of $1.45 per share and down from adjusted earnings of $1.61 in the same period a year earlier.

The company’s third quarter revenue totaled $17.1 billion, a decrease of 7.4% as compared to the third quarter of 2014 and below expectations for revenue of $17.46 billion.

Operational sales results increased 0.8% and the negative impact of currency was 8.2%.

Domestic sales decreased 0.6%. International sales decreased 13.7%, reflecting operational growth of 2.1% and a negative currency impact of 15.8%.

Excluding the net impact of acquisitions, divestitures and hepatitis C sales, on an operational basis, worldwide sales increased 5.6%, domestic sales increased 7.7% and international sales increased 3.8%.

Prior to its earnings announcement, the health care and consumer products company said it approved a $10 billion share repurchase program. The buyback, which J&J said will be financed by issuing debt, has no time limit.

"New and core products drove solid underlying growth for Johnson & Johnson in the quarter," said Alex Gorsky, Chairman and Chief Executive Officer.

The firm now sees full year adjusted earnings per share in a range between $6.15 and $6.20, up from a previous estimate for adjusted earnings between $6.10 and $6.20 per share.

Immediately after the earnings announcement, Johnson & Johnson shares tacked on 0.95%, or 91 cents, in trading prior to the opening bell to $96.90 compared to Monday's closing price of $95.98.

Meanwhile, U.S. equity markets pointed to a weaker open. The Dow futures pointed to a drop of 0.4%, the S&P 500 futures shed 0.4%, while the Nasdaq 100 futures declined 0.5%.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.